SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Feb 12, 2020
Document Date
Feb 12, 2020
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc